GenScript

Jan 13, 2021

GenScript Submits Application with FDA for Use of cPass(TM) SARS-CoV-2 Neutralization Antibody Test in Convalescent Plasma Screening

Nov 09, 2020

GenScript Receives FDA Emergency Use Authorization for World's First SARS-CoV-2 Neutralizing Antibody Detection Kit

Sep 15, 2020

Innatoss Laboratories Launches Neutralizing Antibody Public Testing Service for SARS-CoV-2 in Europe using GenScript's cPass(TM) kit

Apr 01, 2020

GenScript Launches Neoantigen Specific Peptide Synthesis Service for Precision Immuno-oncology Therapeutic Development

Dec 10, 2019

GenScript Releases Precision Mutant Library Services for Drug Development and Synthetic Biology

Sep 23, 2019

GenScript Partners with Harvard University to Develop Ultra-safe Cells Resistant to Natural Viruses

Jun 25, 2019

GenScript Launches Enhanced GenBrick Gene Synthesis Service for Building Synthetic Genomes

Apr 08, 2019

GenScript Launches Beta Testing Program for New Precision Mutant Library Services

Mar 19, 2019

MilliporeSigma to Collaborate with GenScript to Accelerate Cell and Gene Therapy Industrialization in China

Jan 14, 2019

GenScript Launches Novel Technology Licensed from Amgen for Accelerating Protein and Antibody Purification

Jun 12, 2018

GenScript Supports the Development of a Novel HIV Vaccine